Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Long-term Extension Study for Treatment of Breakthrough Cancer Pain With BEMA™ Fentanyl

NCT00696137 is registered in ClinicalTrials.gov with BioDelivery Sciences International as lead sponsor.

NCT NCT00696137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00696137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Long-term Extension Study for Treatment of Breakthrough Cancer Pain With BEMA™ Fentanyl
Lead sponsor
BioDelivery Sciences International
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
July 31, 2009
Enrollment
5 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory depression